False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010

Journal of Medical Screening

Volumn 19, Issue 2, 2012, Pages 77-82

  Garcia, Montse ^a,b   Milà, Núria ^a,b   Binefa, Gemma ^a,b   Borràs, Josep Maria ^a,c,d   Espinàs, Josep Alfons ^a,c,d   Moreno, Víctor ^a,b,d  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c Catalan Cancer Plan   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COLORECTAL TUMOR; EARLY DIAGNOSIS; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; SPAIN;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; SPAIN;

EID: 84864335271     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2012.012013     Document Type: Article

References (26)

1. Halloran S, Launoy G, Zappa M. Evidence for the effectiveness of colorectal cancer screening. In: Segnan N, Patnick J, von Karsa L, eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st edn. Luxembourg: European Commission, Publications Office of the European Union, 2010
2. Muir Gray JA, Patnick J, Blanks RG. Maximizing benefit and minimizing harm of screening. BMJ 2008;336:480-3 (Pubitemid 351347413)
3. Marshall KG. Prevention. How much harm? How much benefit? III Physical, psychological and social harm. Can Med Assoc J 1996;155:169-76
4. Robinson MH, Hardcastle JD, Moss SM, et al. The risks of screening: data from the Nottingham randomized controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999;45:588-92 (Pubitemid 29447830)
5. The UK CRC Screening Pilot Evaluation Team (2003) Evaluation of the UK Colorectal Cancer Screening Pilot Final Report. http://www. cancerscreening.nhs. uk/bowel/finalreport.pdf (last accessed 30 December 2011)
6. Croswell JM, Kramer BS, Kreimer AR, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med 2009;7:212-22
7. Feldman W. How serious are the adverse effects of screening? J Gen Intern Med 1990;5(Suppl 5):S50-3 (Pubitemid 20325613)
8. Peris M, Espinas JA, Muñoz L, Navarro M, Binefa G, Borras JM. Lessons learnt from a population-based pilot program for colorectal cancer screening in Catalonia (Spain). J Med Screen 2007;14:81-6 (Pubitemid 47067762)
9. Garcia M, Binefa G, Milà N, et al. Evaluating colorectal cancer screening strategies (immunological test vs. biochemical test) in Catalonia, Spain 2008-2010. Rev Esp Salud Pública 2011;85:593-602
10. de Bruin JP, Bovenhuis H, van Noord PA, et al. The role of genetic factors in age at natural menopause. Hum Reprod 2001;16:2014-8 (Pubitemid 32916239)
11. Brenner H, Haug U, Hundt S. Sex differences in performance of aecal occult blood testing. Am J Gastroenterol 2010;105:2457-64
12. Myers AM, Saunders CRG, Chalmers DG. The haemoglobin level of fit elderly people. Lancet 1968;2:261-3
13. Castells X, Molins E, Macià F. Cumulative false-positive recall rate and association with participant-related factors in a population-based breast cancer screening programme. J Epidemiol Community Health 2006;60:316-21
14. Petersen BT. Quality assurance for endoscopists. Best Pract Res Clin Gastroenterol 2011;25:349-60
15. Moss S, Ancelle-Park R, Brenner H. Evaluation and interpretation of screening outcomes. In: Segnan N, Patnick J, von Karsa L, eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st edn. Luxembourg: European Commission, Publications Office of the European Union: 71-102
16. Ko CW, Riffle S, Michaels L, et al. Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol 2010;8:166-73
17. Van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101:343-50 (Pubitemid 43381678)
18. Brenner H, Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 2001;85:972-6 (Pubitemid 33015999)
19. Brenner H, Chang-Claude J, Seiler CM, Stürmer T, Hoffmeister M. Does a negative screening colonoscopy ever need to be repeated? Gut 2006;55:1145-50 (Pubitemid 44085683)
20. Brenner H, Haug U, Arndt V, Stegmaier C, Altenhofen L, Hoffmeister M. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology 2010;138:870-6
21. Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359:1218-24
22. Brenner H, Chang-Claude J, Seiler CM, Hoffmeister. Interval cancers after negative colonoscopy: population-based case-control study. Gut 2012. Dec 26 [Epub ahead of print]
23. Haug U, Knudsen AB, Kuntz KM. How should individuals with a false-positive aecal occult blood test for colorectal cancer be managed? A decision analysis. Int J Cancer 2012. Feb 5 [Epub ahead of print]
24. Parker MA, Robinson MHE, Scholefield JH, Hardcastle JD. Psychiatric morbidity and screening for colorectal cancer. J Med Screen 2002;9:7-10 (Pubitemid 34327135)
25. Lindholm E, Berglund B, Kewwhnter J, Haglind E. Worry associated with screening for colorectal carcinomas. Scand J Gastroenterol 1997;32:238-45 (Pubitemid 27105299)
26. Mant D, Fitzpatrick R, Hogg A, et al. Experiences of patients with falsepositive results from colorectal cancer screening. Br J Gen Pract 1990;40:423-5